High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique

被引:27
作者
Estaleva, Calvina E. L. [1 ,2 ,3 ]
Zimba, Tomas F. [1 ,2 ]
Sekyere, John Osei [3 ]
Govinden, Usha [3 ]
Chenia, Hafizah Y. [4 ]
Simonsen, Gunnar S. [3 ,5 ,6 ]
Haldorsen, Bjorg [5 ]
Essack, Sabiha Y. [3 ]
Sundsfjord, Arnfinn [3 ,5 ,6 ]
机构
[1] Maputo Cent Hosp, Microbiol Lab, Maputo, Mozambique
[2] High Inst Hlth Sci ISCISA, Maputo, Mozambique
[3] Univ KwaZulu Natal, Sch Hlth Sci, Antimicrobial Res Unit, Durban, South Africa
[4] Univ KwaZulu Natal, Sch Life Sci, Discipline Microbiol, Durban, South Africa
[5] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway
[6] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, NO-9037 Tromso, Norway
关键词
Escherichia coli; Multidrug resistance; Extended-spectrum beta-lactamase; Plasmid-mediated AmpC beta-lactamase; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ANTIMICROBIAL DRUG-RESISTANCE; SPECTRUM BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; TRENDS; EPIDEMIOLOGY; AFRICA; GENES;
D O I
10.1186/s12879-020-05696-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Epidemiological data of cephalosporin-resistant Enterobacterales in Sub-Saharan Africa is still restricted, and in particular in Mozambique. The aim of this study was to detect and characterize extended-spectrum beta-lactamase (ESBL) - and plasmid-mediated AmpC (pAmpC)-producing clinical strains of Escherichia coli at Maputo Central Hospital (MCH), a 1000-bed reference hospital in Maputo, Mozambique. Methods: A total of 230 clinical isolates of E. coli from urine (n = 199) and blood cultures (n = 31) were collected at MCH during August-November 2015. Antimicrobial susceptibility testing was performed by the disc diffusion method and interpreted according to EUCAST guidelines. Isolates with reduced susceptibility to 3rd generation cephalosporins were examined further; phenotypically for an ESBL-/AmpC-phenotype by combined disc methods and genetically for ESBL- and pAmpC-encoding genes by PCR and partial amplicon sequencing as well as genetic relatedness by ERIC-PCR. Results: A total of 75 isolates with reduced susceptibility to cefotaxime and/or ceftazidime (n = 75) from urine (n = 58/199; 29%) and blood (n = 17/31; 55%) were detected. All 75 isolates were phenotypically ESBL-positive and 25/75 (33%) of those also expressed an AmpC-phenotype. ESBL-PCR and amplicon sequencing revealed a majority of bla(CTX-M) (n = 58/75; 77%) dominated by bla(CTX-M-15). All AmpC-phenotype positive isolates (n = 25/75; 33%) scored positive for one or more pAmpC-genes dominated by bla(MOX/FOX). Multidrug resistance (resistance >= three antibiotic classes) was observed in all the 75 ESBL-positive isolates dominated by resistance to trimethoprim-sulfamethoxazole, ciprofloxacin and gentamicin. ERIC-PCR revealed genetic diversity among strains with minor clusters indicating intra-hospital spread. Conclusion: We have observed a high prevalence of MDR pAmpC- and/or ESBL-producing clinical E. coli isolates with FOX/MOX and CTX-Ms as the major beta-lactamase types, respectively. ERIC-PCR analyses revealed genetic diversity and some clusters indicating within-hospital spread. The overall findings strongly support the urgent need for accurate and rapid diagnostic services to guide antibiotic treatment and improved infection control measures.
引用
收藏
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 2017, EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance
[2]   Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia coli fecal-sample isolates from healthy chickens [J].
Briñas, L ;
Moreno, MA ;
Zarazaga, M ;
Porrero, C ;
Sáenz, Y ;
García, M ;
Dominguez, L ;
Torres, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :2056-2058
[3]   Updated Functional Classification of β-Lactamases [J].
Bush, Karen ;
Jacoby, George A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) :969-976
[4]   Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria [J].
Bush, Karen ;
Fisher, Jed F. .
ANNUAL REVIEW OF MICROBIOLOGY, VOL 65, 2011, 65 :455-478
[5]   Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia [J].
Cherif, Thouraya ;
Saidani, Mabrouka ;
Decre, Dominique ;
Boubaker, Ilhem Boutiba-Ben ;
Arlet, Guillaume .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) :44-51
[6]   Faecal colonization of E-coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students [J].
Chirindze, L. M. ;
Zimba, T. F. ;
Sekyere, J. O. ;
Govinden, U. ;
Chenia, H. Y. ;
Sundsfjord, A. ;
Essack, S. Y. ;
Simonsen, G. S. .
BMC INFECTIOUS DISEASES, 2018, 18
[7]   The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System [J].
de Kraker, M. E. A. ;
Jarlier, V. ;
Monen, J. C. M. ;
Heuer, O. E. ;
van de Sande, N. ;
Grundmann, H. .
CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (09) :860-868
[8]   Plasmid-mediated resistance is going wild [J].
Dolejska, Monika ;
Papagiannitsis, Costas C. .
PLASMID, 2018, 99 :99-111
[9]   Ceftriaxone-resistant Salmonella enterica serotype Newport, France [J].
Egorova, Svetlana ;
Timinouni, Mohammed ;
Demartin, Marie ;
Granier, Sophie A. ;
Whichard, Jean M. ;
Sangal, Vartul ;
Fabre, Laetitia ;
Delaune, Aurelia ;
Pardos, Maria ;
Millemann, Yves ;
Espie, Emmanuelle ;
Achtman, Mark ;
Grimont, Patrick A. D. ;
Weill, Francois-Xavier .
EMERGING INFECTIOUS DISEASES, 2008, 14 (06) :954-957
[10]   The epidemiology of urinary tract infection [J].
Foxman, Betsy .
NATURE REVIEWS UROLOGY, 2010, 7 (12) :653-660